Concerns over FDA's increasing use of expedited development and approval pathways

Two studies carried out by US researchers raise questions about whether most new drugs are any more effective than existing products or whether they have been adequately assessed before approval.

from Today's Healthcare News -- ScienceDaily http://ift.tt/1OWkS5l